arrow
M

Myriam Chimen

University of Birmingham
H指数:19
被引数:1,891

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Divergent Roles of Skeletal Muscle 11β-HSD1 in Age-Related and Chronic Kidney Disease-Associated Sarcopenia

骨骼肌11β-HSD1在年龄相关性和慢性肾病相关性肌少症中的不同作用

2026-04-300
OA
PEPITEM Regulates the Synovial Microenvironment During Immune-Mediated Inflammatory Arthritis to Limit Disease

PEPITEM 在免疫介导性炎性关节炎期间调控滑膜微环境以限制疾病

2026-04-010
OAAI
Corrigendum to “Platelet extracellular vesicles drive monocyte differentiation into inflammatory foam cells in peripheral arterial disease” [Biomed. & Pharmacother. 2026 (196) 119122]

勘误:“Platelet extracellular vesicles drive monocyte differentiation into inflammatory foam cells in peripheral arterial disease” [Biomed. & Pharmacother. 2026 (196) 119122]

2026-03-220
OAAI
Herbal terpenoids activate autophagy and mitophagy through modulation of bioenergetics and protect from metabolic stress, sarcopenia and epigenetic aging

植物萜类化合物通过调节生物能量学来激活自噬和线粒体自噬,并保护机体免受代谢应激、肌肉减少症和表观遗传衰老的影响。

2025-09-240
OAAI
ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells

ISB 2001三特异性T细胞接合器显示出强烈的肿瘤细胞毒性并克服了多发性骨髓瘤细胞的免疫逃逸机制

2024-09-112
OAAI
Therapeutic avenues in bone repair: Harnessing an anabolic osteopeptide, PEPITEM, to boost bone growth and prevent bone loss (vol 5, 101574, 2024)
2024-08-010
OAAI
Therapeutic avenues in bone repair: Harnessing an anabolic osteopeptide, PEPITEM, to boost bone growth and prevent bone loss
2024-05-013
OAAI
Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma
2024-03-061
OAAI
Overcoming mechanisms of escape from treatments for multiple myeloma with ISB 2001, a potential first-inclass trispecific BCMA and CD38 targeted T cell engager
2023-04-042
PRE
Galectin-9: A novel promoter of atherosclerosis progression
2022-12-0118
PRE